Maximizing the population benefit from thrombolysis in acute ischemic stroke: A modeling study of in-hospital delays

Stroke

Volumn 43, Issue 10, 2012, Pages 2706-2711

  Monks, Thomas ^a   Pitt, Martin ^a   Stein, Ken ^a   James, Martin ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

emergency treatment of stroke; simulation; thrombolysis

Indexed keywords

ALTEPLASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL PRACTICE; EMERGENCY TREATMENT; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; SIMULATION; TREATMENT OUTCOME;

AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FIBRINOLYTIC AGENTS; HUMANS; INPATIENTS; MODELS, ORGANIZATIONAL; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TRIAGE;

EID: 84866735490     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.663187     Document Type: Article

References (31)

1. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;3759727:1695-1703.
2. Saver JL, Levine SR. Alteplase for ischaemic stroke-much sooner is much better. Lancet. 2010;375:1667-1668.
3. Asplund K, Glader E-L, Norrving B, Eriksson M. Effects of extending the time window of thrombolysis to 4.5 hours. Observations in the Swedish Stroke Register (Riks-Stroke). Stroke. 2011;42:2492-2497.
4. Intercollegiate Stroke Working Party. National Sentinel Stroke Audit 2010 Round 7. London, UK: Royal College of Physicians of London; 2011.
5. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Xin Z, Olson DM, et al. The 'golden hour' and acute brain ischemia; presenting features and lytic therapy in-30 000 patients arriving within 60 minutes of stroke onset. Stroke. 2010;41:1431-1439.
6. Ferrari J, Knoflach M, Kiechl S, Willeit J, Matosevic B, Seyfang L, et al. Stroke thrombolysis: having more time translates into delayed therapy: data from the Austrian Stroke Unit Registry. Stroke. 2010;419: 2001-2004.
7. Mihout M, Cordonnier C, Girard-Buttaz I, Leys D. Thrombolysis for ischaemic stroke: impact of the extension of the time-window in daily practice [Letter]. J Neurol Neurosurg Psychiatry. 2012;832:227.
8. Heo JH, Kim YD, Nam HS, Hong KS, Ahn SH, Cho HJ, et al. A computerised in-hospital alert system for thrombolysis in acute stroke. Stroke. 2010;41:1978-1983.
9. Romano JG, Muller N, Merino JG, Forteza AM, Koch S, Rabinstein AA. In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival. Neurol Res. 2007;29:664-666. (Pubitemid 350086063)
10. Pitt M, Monks T, Agarwal P, Worthington D, Ford GA, Lees KR, et al. Will delays in treatment jeopardise the population benefit from extending the time window for stroke thrombolysis? [Abstract]. Stroke. 2011;6(suppl 2)5.
11. Mustanoja S, Meretoja A, Putaala J, Viitanen V, Curtze S, Atula S, et al. Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke. 2011;42:102-106.
12. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke. Circulation. 2011;123:750-758.
13. Strbian D, Soinne L, Sairanen T, Happola O, Lindsberg PJ, Tatlisumak T, et al. Ultraearly thrombolysis in acute ischemic stroke is associated with better outcome and lower mortality. Stroke. 2010;41:721-716.
14. Marler JR, Winters JP, and Emr M. The National Institute of Neurological Disorders and Stroke. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 1997.
15. Brailsford SC, Harper PR, Patel B, Pitt M. An analysis of the academic literature on simulation and modelling in health care. Journal of Simulation. 2009;33:130-140.
16. Fone D, Hollinghurst S, Temple M, Round A, Lester N, Weightman A, et al. Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health. 2003;254:325-335. (Pubitemid 38173604)
17. Gunal M, Pidd M. Discrete event simulation for performance modelling in health care: a review of the literature. Journal of Simulation. 2011;4: 42-51.
18. Katsaliaki K, Mustafee N. Applications of simulation within the healthcare context. Journal of the Operational Research Society. 2011; 628:1431-1451.
19. Bayer S, Petsoulas C, Cox B, Honeyman A, Barlow J. Facilitating stroke care planning through simulation modelling. Health Informatics Journal. 2010;162:129-143.
20. Cordeaux C, Hughes A, Elder M. Simulating the impact of change: implementing best practice in stroke care. London Journal of Primacy Care. 2011;4:33-37.
21. Nor A, Davis J, Sen B, Shipsey D, Louw S, Dyker A, et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol. 2005;411:727-734. (Pubitemid 41457288)
22. Whiteley WN, Wardlaw JM, Dennis MS, Sandercock PAG. Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study. J Neurol Neurosurg Psychiatry. 2011;82:1006-1010.
23. Intercollegiate Stroke Working Party. Stroke Improvement National Audit Programme (SINAP) Comprehensive Report. London, UK: Royal College of Physicians of London; 2011.
24. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;99:886-874.
25. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target's stroke initiative. Stroke. 2011;42:2983-2989.
26. Kim SK, L.S., Bae HJ, Lee YS, Kim SY, Kang MJ, Cha JK. Pre-hospital notification reduced the door-to-needle time for iv tPA in acute ischaemic stroke. Eur J Neurol. 2009;1612:1331-1335.
27. Rudd AG, Hoffman A, Grant R, Campbell JT, Lowe D; on behalf of the Intercollegiate Working Party for Stroke. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry. 2011;821:14-19.
28. National Stroke Strategy. London, UK: Department of Health; 2007.
29. The IST-3 Collaborative Group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third International Stroke Trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352-2363.
30. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012; 379:2364-2372.
31. Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006;113: 1079-1085.